Justin Roby

Mr. Justin Roby


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in Molecular Cell
Verified
Journal Article
Closed access
LALauren D. Aarreberg
Lauren D. Aarreberg
KEKatharina Esser-Nobis
Katharina Esser-Nobis
CDConnor Driscoll
Connor Driscoll
ASAndrey Shuvarikov
Andrey Shuvarikov
JRJustin Roby
Justin Roby
MGMichael Gale
Michael Gale

27 January 2014 in Viruses
Verified
Journal Article
Open access
PDF file
JRJustin Roby
Justin Roby
Gorben PijlmanGorben Pijlman
Gorben Pijlman
JWJeffrey Wilusz
Jeffrey Wilusz
AKAlexander Khromykh
Alexander Khromykh
Flaviviruses are a large group of positive strand RNA viruses transmitted by arthropods that include many human pathogens such as West Nile virus (WNV), Japanese encephalitis virus (JEV), yellow fever virus, dengue virus, and tick-borne encephalitis virus. All members in this genus tested so far are shown to produce a unique subgenomic flavivirus RNA (sfRNA) derived from the 3' untranslated region (UTR). sfRNA is a product of incomplete degradation of genomic RNA by the cell 5'–3' exoribonuclease XRN1 which stalls at highly ordered secondary RNA structures at the beginning of the 3'UTR. Generation of sfRNA results in inhibition of XRN1 activity leading to an increase in stability of many cellular mRNAs. Mutant WNV deficient in sfRNA generation was highly attenuated displaying a marked decrease in cytopathicity in cells and pathogenicity in mice. sfRNA has also been shown to inhibit the antiviral activity of IFN-α/β by yet unknown mechanism and of the RNAi pathway by likely serving as a decoy substrate for Dicer. Thus, sfRNA is involved in modulating multiple cellular pathways to facilitate viral pathogenicity; however the overlying mechanism linking all these multiple functions of sfRNA remains to be elucidated.

5 February 2018 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
KWKristina Adams Waldorf
Kristina Adams Waldorf
BNBranden R Nelson
Branden R Nelson
JSJennifer E Stencel-Baerenwald
Jennifer E Stencel-Baerenwald
CSColin Studholme
Colin Studholme
RKRaj P Kapur
Raj P Kapur
LRLakshmi Rajagopal
Lakshmi Rajagopal

18 November 2019 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
JSJohannes Schwerk
Johannes Schwerk
FSFrank W. Soveg
Frank W. Soveg
ARAndrew P. Ryan
Andrew P. Ryan
KTKerri R. Thomas
Kerri R. Thomas
LHLauren D. Hatfield
Lauren D. Hatfield
RSRam Savan
Ram Savan

1 July 2019 in Journal of Virology
Verified
Journal Article
Closed access
PDF file
KEKatharina Esser-Nobis
Katharina Esser-Nobis
LALauren D. Aarreberg
Lauren D. Aarreberg
JRJustin Roby
Justin Roby
MFMarian R. Fairgrieve
Marian R. Fairgrieve
RGRichard Green
Richard Green
MGMichael Gale
Michael Gale
Zika Virus (ZIKV), discovered in 1947, is divided into African and Asian lineages. Pandemic outbreaks caused by currently emerging Asian lineage strains are accompanied by high rates of neurological disorders and exemplify the global health burden associated with this virus. Here we compared virological and innate immunological aspects of two ZIKV strains from the Asian lineage, an emerging Brazilian strain and a less-pathogenic Cambodian strain, and the prototypic African lineage ZIKV strain from Uganda. Compared to the replication of other ZIKV strains, the replication of ZIKV Brazil was less sensitive to the antiviral actions of interferon (IFN), while infection with this strain induced weaker and delayed innate immune responses in vitro . Our data suggest that ZIKV Brazil directs a passive strategy of innate immune evasion that is reminiscent of a stealth virus. Such strain-specific properties likely contribute to differential pathogenesis and should be taken into consideration when choosing virus strains for future molecular studies.

7 April 2020 in Cells
Verified
Journal Article
Open access
PDF file
JRJustin Roby
Justin Roby
KEKatharina Esser-Nobis
Katharina Esser-Nobis
EDElyse C. Dewey-Verstelle
Elyse C. Dewey-Verstelle
MFMarian R. Fairgrieve
Marian R. Fairgrieve
JSJohannes Schwerk
Johannes Schwerk
MGMichael Gale
Michael Gale
Pathogenic flaviviruses antagonize host cell Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling downstream of interferons α/β. Here, we show that flaviviruses inhibit JAK/STAT signaling induced by a wide range of cytokines beyond interferon, including interleukins. This broad inhibition was mapped to viral nonstructural protein 5 (NS5) binding to cellular heat shock protein 90 (HSP90), resulting in reduced Janus kinase–HSP90 interaction and thus destabilization of unchaperoned JAKs (and other kinase clients) of HSP90 during infection by Zika virus, West Nile virus, and Japanese encephalitis virus. Our studies implicate viral dysregulation of HSP90 and the JAK/STAT pathway as a critical determinant of cytokine signaling control during flavivirus infection.